Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Parsaclisib

SKU: orb1218831

Description

Parsaclisib is a potent and selective inhibitor of PI3Kδ(IC50 of 1 nM at 1 mM ATP).

Images & Validation

Key Properties

CAS Number1426698-88-5
MW432.88
Purity>98% (HPLC)
FormulaC20H22ClFN6O2
SMILESCCOc(c([C@H](C)n1nc(C)c2c(N)ncnc12)c1)c([C@@H](C2)CNC2=O)c(F)c1Cl
TargetPI3K
SolubilityDMSO:122 mg/mL (281.83 mM; Need ultrasonic)

Bioactivity

In Vivo
Parsaclisib (10 mg/kg; oral gavage twice daily for 7-19 days) inhibits tumor growth in the BALB/c mice bearing the A20 murine lymphoma cells. Parsaclisib (0.1-10 mg/kg; p.o. twice daily) slows Pfeiffer xenograft tumor growth in a dose-dependent manner. And Parsaclisib was well tolerated. Parsaclisib (0.5-1 mg/kg; a single p.o.) inhibits pAKT (Ser473) in Pfeiffer subcutaneous mouse xenograft models. Animal model: Female BALB/c mice (5-9 weeks) were inoculated with A20 cells. Dosage: 10 mg/kg. Administration: Oral gavage twice daily for 7-19 days. Result: Resulted in significant tumor growth inhibition (TGI). Reduced the percentage of Tregs (CD4+CD25+FOXP3+) in tumors and spleens. Increased the ratio of CD4+ and CD8+ T cells to Tregs in spleens and tumors. Decreased the number of CD4+CD44high and CD8+CD44high T cells in both spleens and tumors.
In Vitro
Parsaclisib (0.1-3000 nM; 4 d) inhibits proliferation of MCL and DLBCL cell lines. Parsaclisib (0.1-1000 nM; 2 h) inhibits anti-IgM-induced pAKT (Ser473) in the Ramos Burkitt’s lymphoma cell line, with an IC50 of 1 nM. Parsaclisib inhibits the proliferation of human, dog, rat, and mouse primary B cells after activation of these receptors, with IC50s ranging from 0.2 to 1.7 nM. Cell Proliferation Assay Cell line: Jeko-1, Mino, JVM2, Rec-1, Pfeiffer, SU-DHL-5, SU-DHL-6, WSU-NHL, SU-DHL-4, SU-DHL-8, and WILL-2 cells. Concentration: 0.1-3000 nM Incubation time: 4 days. Result: Resulted in a maximal inhibition of 70-90%, with IC50s of ≤10 nM in the four MCL cell lines. Pfeiffer, SU-DHL-5, SU-DHL-6, and WSU-NHL were highly sensitive, with IC50s from 2 to 8 nM.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

INCB050465

Similar Products

  • Parsaclisib hydrochloride [orb1699720]

    1995889-48-9

    469.34

    C20H23Cl2FN6O2

    100 mg
  • Parsaclisib [orb1309280]

    99.02% (May vary between batches)

    1426698-88-5

    432.88

    C20H22ClFN6O2

    5 mg, 25 mg, 1 mg, 10 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
  • Parsaclisib HCl [orb1218518]

    >98% (HPLC)

    1995889-48-9

    469.34

    C20H23Cl2FN6O2

    50 mg, 100 mg, 5 mg, 500 mg, 1 g, 200 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 510.00
10 mg
$ 820.00
25 mg
$ 1,310.00
50 mg
$ 1,800.00
100 mg
$ 2,430.00